Coya Therapeutics Inc.

NASDAQ: COYA · Real-Time Price · USD
6.09
0.41 (7.12%)
At close: Aug 15, 2025, 3:59 PM
6.20
1.81%
After-hours: Aug 15, 2025, 07:54 PM EDT

Coya Therapeutics Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
163.62K 257.88K 1.95K n/a 3.42M 126.84K 6M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
6.84K n/a 6.84K 6.84K n/a 6.84K 6.84K 6.84K 6.84K 6.84K 6.84K 12.46K n/a n/a 10.19K 2.53K n/a n/a
Gross Profit
156.78K 257.88K -4.89K -6.84K 3.42M 120K 6M -6.84K -6.84K -6.84K -6.84K -12.46K n/a n/a -10.19K -2.53K n/a n/a
Operating Income
-6.41B -7.68M -4.08M -4.45M -3.24M -5.48M 1.81M -3.56M -3.25M -2.9M -2M -2.66M -3.45M -1.7M -1.6M -1.33M -970K -970K
Interest Income
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
-6.09B -7.31M -3.64M -4.02M -2.89M -5.05M 1.99M -3.42M -3.1M -2.74M -3.11M -4.02M -3.41M -1.7M -1.63M -1.33M -966K -966K
Net Income
-6.09B -7.31M -2.92M -4.02M -2.89M -5.05M 1.27M -3.42M -3.1M -2.57M -3.11M -4.02M -3.41M -1.71M -1.63M -1.33M -966K -966K
Selling & General & Admin
2.91B 2.71M 2.14M 2.22M 2.09M 2.44M 2.38M 1.97M 1.83M 1.66M 898.65K 1.24M 2M 717.52K 732.15K 543.29K 518.3K 518.3K
Research & Development
3.66B 5.21M 1.94M 2.22M 4.57M 3.14M 1.8M 1.59M 1.42M 1.23M 1.1M 1.41M 1.45M 978.8K 855.81K 785.36K 450.48K 450.48K
Other Expenses
-6.56B 7K 7K 6K 1K n/a 7.23K 7K n/a 6.84K 6.84K 39.42K 10.94K 4.03K n/a n/a n/a n/a
Operating Expenses
6.57M 7.93M 4.08M 4.45M 6.66M 5.58M 4.19M 3.56M 3.25M 2.9M 2M 2.66M 3.45M 1.7M 1.6M 1.33M 966.07K 966.07K
Interest Expense
n/a n/a n/a n/a n/a n/a 163.63K n/a n/a n/a 1.1M n/a n/a 3.02K n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
6.58M 7.93M 4.08M 4.45M 6.66M 5.58M 4.19M 3.56M 3.25M 2.9M 2M 2.66M 3.45M 1.7M 1.6M 1.33M 966.07K 966.07K
Income Tax Expense
n/a n/a -720.29K n/a n/a n/a 723.85K n/a n/a -164K n/a n/a -22.34K 3.02K n/a n/a n/a n/a
Shares Outstanding (Basic)
16.72M 16.72M 16.36M 15.22M 14.91M 14.46M 10.16M 9.95M 9.95M 9.95M 9.95M 9.68M 6.6M 6.6M 6.6M 9.68M 2.59M 2.59M
Shares Outstanding (Diluted)
16.72M 16.72M 16.36M 15.22M 14.91M 14.46M 10.16M 9.95M 9.95M 9.95M 9.95M 9.68M 6.6M 6.6M 6.6M 9.68M 2.59M 2.59M
EPS (Basic)
-0.36 -0.44 -0.18 -0.26 -0.19 -0.35 0.12 -0.34 -0.31 -0.26 -0.42 -0.42 -0.52 -0.26 -0.25 -0.14 -0.37 -0.37
EPS (Diluted)
-0.36 -0.44 -0.18 -0.26 -0.19 -0.35 0.12 -0.34 -0.31 -0.26 -0.42 -0.42 -0.52 -0.26 -0.25 -0.14 -0.37 -0.37
EBITDA
-6.41B -7.67M -4.07M -4.44M -3.23M -5.48M 1.82M -3.56M -3.25M -2.89M -2M -2.65M -3.44M -1.7M -1.61M -1.33M -969K -969K
EBIT
-6.09M -7.68M -4.08M -4.45M -3.24M -5.46M 1.81M -3.56M -3.25M -2.9M -2M -2.53M -3.45M -1.7M -1.62M -1.33M -970K -970K
Depreciation & Amortization
6.84K 6.84K 6.84K 6.84K 6.84K 6.84K 6.84K 6.84K 6.84K 6.84K 6.84K 12.46K 4.03K 4.03K 10.19K 2.53K 1.71K 1.71K